One-Year Outcomes in Subjects Developing Macular Neovascularization While Undergoing Avacincaptad Pegol Therapy for Geographic Atrophy.

Rush RB, Klein W, Rush SW, Reinauer R

Open source

DOI
10.2147/opth.s498985
Published
2025
Container
Clinical ophthalmology (Auckland, N.Z.)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/opth.s498985,
  title = {One-Year Outcomes in Subjects Developing Macular Neovascularization While Undergoing Avacincaptad Pegol Therapy for Geographic Atrophy.},
  author = {Rush RB and Klein W and Rush SW and Reinauer R},
  year = {2025},
  journal = {Clinical ophthalmology (Auckland, N.Z.)},
  doi = {10.2147/opth.s498985},
  url = {https://doi.org/10.2147/opth.s498985}
}

RIS

TY  - JOUR
TI  - One-Year Outcomes in Subjects Developing Macular Neovascularization While Undergoing Avacincaptad Pegol Therapy for Geographic Atrophy.
AU  - Rush RB
AU  - Klein W
AU  - Rush SW
AU  - Reinauer R
PY  - 2025
JO  - Clinical ophthalmology (Auckland, N.Z.)
DO  - 10.2147/opth.s498985
UR  - https://doi.org/10.2147/opth.s498985
ER  - 

APA

RB, R., W, K., SW, R., & R, R. (2025). One-Year Outcomes in Subjects Developing Macular Neovascularization While Undergoing Avacincaptad Pegol Therapy for Geographic Atrophy.. Clinical ophthalmology (Auckland, N.Z.). https://doi.org/10.2147/opth.s498985

Source records